Fidelity Investments’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13
| Closed | -$13 | – | 5717 |
|
|
2023
Q3 | $13 | Buy |
+13
| New | +$9 | ﹤0.01% | 5154 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5207 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5060 |
|
|
2017
Q4 | – | Sell |
-2,168
| Closed | -$1.64M | – | 2715 |
|
|
2017
Q3 | $1.64M | Sell |
2,168
-658
| -23% | -$520K | ﹤0.01% | 2359 |
|
|
2017
Q2 | $2.41M | Sell |
2,826
-105
| -4% | -$76.8K | ﹤0.01% | 2313 |
|
|
2017
Q1 | $2.06M | Sell |
2,931
-265
| -8% | -$187K | ﹤0.01% | 2348 |
|
|
2016
Q4 | $2.32M | Buy |
3,196
+57
| +2% | +$46.3K | ﹤0.01% | 2354 |
|
|
2016
Q3 | $3.01M | Buy |
3,139
+62
| +2% | +$78.2K | ﹤0.01% | 2293 |
|
|
2016
Q2 | $4.39M | Sell |
3,077
-85
| -3% | -$109K | ﹤0.01% | 2213 |
|
|
2016
Q1 | $3.89M | Sell |
3,162
-97
| -3% | -$112K | ﹤0.01% | 2233 |
|
|
2015
Q4 | $4.21M | Buy |
3,259
+330
| +11% | +$431K | ﹤0.01% | 2244 |
|
|
2015
Q3 | $4.24M | Buy |
2,929
+385
| +15% | +$743K | ﹤0.01% | 2221 |
|
|
2015
Q2 | $5.61M | Sell |
2,544
-49
| -2% | -$154K | ﹤0.01% | 2201 |
|
|
2015
Q1 | $7.72M | Buy |
2,593
+74
| +3% | +$237K | ﹤0.01% | 2095 |
|
|
2014
Q4 | $8.33M | Buy |
2,519
+31
| +1% | +$110K | ﹤0.01% | 2066 |
|
|
2014
Q3 | $8.78M | Buy |
2,488
+64
| +3% | +$249K | ﹤0.01% | 2062 |
|
|
2014
Q2 | $9.32M | Sell |
2,424
-175
| -7% | -$658K | ﹤0.01% | 2080 |
|
|
2014
Q1 | $10.6M | Sell |
2,599
-13
| -0.5% | -$58K | ﹤0.01% | 1997 |
|
|
2013
Q4 | $9.71M | Buy |
2,612
+274
| +12% | +$1.04M | ﹤0.01% | 1976 |
|
|
2013
Q3 | $9.21M | Buy |
2,338
+954
| +69% | +$7.16M | ﹤0.01% | 1974 |
|
|
2013
Q2 | $13.6M | Buy |
+1,384
| New | +$15.3M | ﹤0.01% | 1824 |
|
Other funds holding FRTX
Fidelity Investments's FRTX Position: Q4 2023 in Review
Fidelity Investments sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2023, closing a stake of 13 shares — an estimated $13 sold.
Fidelity Investments first reported a position in FRTX in Q2 2013 and held it in 19 quarters. The position peaked at $13.6M in Q2 2013. 1 fund tracked by Wall St. Rank holds FRTX as of Q4 2023.
- Fidelity Investments reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Fidelity Investments sold 13 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $13.
- Fidelity Investments first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 19 quarters.
- Fidelity Investments's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $13.6M in Q2 2013.
- 1 fund tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2023.
Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.